Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis - Wikidata - wikimedia - TriplyDB

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

http://www.wikidata.org/entity/Q28346140

about

Defensins: The Case for Their Use against Mycobacterial Infections Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance Neutrophil-mediated mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice Azurophil granule proteins constitute the major mycobactericidal proteins in human neutrophils and enhance the killing of mycobacteria in macrophages.Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells.Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae.Revisiting eukaryotic anti-infective biotherapeutics.Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers.The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice Induction of β-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis.Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-Guérin Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.Polymorphisms in α-Defensin-Encoding DEFA1A3 Associate with Urinary Tract Infection Risk in Children with Vesicoureteral Reflux.Prophylactic potential of defensins and L-isoleucine in tuberculosis household contacts: an experimental model.Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis.Immunotherapy for human TB: evidence for adjuvant activities of some host defense peptides against TB.Cryptdin-2: a novel therapeutic agent for experimental Salmonella Typhimurium infection.

P2860

Q28067137-552EB504-F734-4721-9167-CEBCC0D04AA0 Q28488709-E85146B6-B847-456C-B50E-8B26BE020A6E Q33788015-D4B9F32B-0EBA-4818-9948-C7058262DF2D Q34131101-96D5D6F7-7C77-4D82-AB67-8AD1584FD41D Q34515757-7FB7547E-DF34-4CE5-A084-B928B0A99898 Q34655555-BA2F17EE-10F0-4B7C-9813-6EE607532561 Q37340656-44B22E20-3FA0-4EE5-B24B-4DDDF8E8B952 Q38073892-408BB988-A4FC-4045-AEC0-321E17F2F647 Q38148589-3530A150-1C81-4B52-93E0-038F9282AF34 Q39132044-69995ADB-9077-49B4-B126-2947AAF342A4 Q39607841-F20E8768-B539-438E-AA11-238FB9C6424E Q39968181-94520631-42B9-43B4-95F6-BCA6C05E23DC Q40348437-5DB59B1A-02AB-4427-AACB-805724FF1509 Q40768537-1E20F5E9-6F46-4AD5-994D-140CA57CD6D3 Q41169862-4440B548-ADDD-4071-B45F-B08BEDA961E5 Q47093744-80DF7A9C-30B5-4FF3-BBC3-7EC9C32B933F Q48076873-F48812F6-4E6C-42B2-8D96-8EADB4310C10 Q50050018-F12083E1-0DBD-464E-9C5F-9467EC2A941B

P2860

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

http://www.wikidata.org/entity/Q28346140

description

2001 nî lūn-bûn

@nan

2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@ast

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@en

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@nl

type

label

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@ast

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@en

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@nl

prefLabel

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@ast

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@en

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@nl

P1433

Q28346140-CCE4551E-CD5D-4D82-B53D-10797113A6DB

P1476

Q28346140-6503AD94-F2F4-46A2-8E4E-989FD4296EC4

P2093

Q28346140-8F2F2346-7DCE-48C9-A09A-5784B36CF9E7

Q28346140-B2FEC83C-838B-4BC8-B28B-7B87BC2BE305

Q28346140-E6199C4B-C022-4BB9-BF64-CFFBACDACB82

P2860

Q28346140-0E29E70F-EC4B-458B-8B53-72F2EE9B73B0

Q28346140-1ED8E732-91AA-4F69-A6FB-98A3E71114D7

Q28346140-5FE86837-6670-491A-B822-F5FD44135419

Q28346140-69ED9CB9-4F7F-4DCF-A657-8BA9EECCA7C4

Q28346140-F9E7890B-CE27-4E6E-A075-1648C4E34764

Q28346140-FBE221D4-0EBA-4337-A337-897611E65375

Q28346140-FF41437F-26F6-425B-A5C1-F79B0C7B8602

P304

Q28346140-407F82E0-C5B1-4552-B14D-E374751838FC

P31

Q28346140-359FEE24-1690-4ABD-AD3B-C10F4271A543

P3181

Q28346140-93E625D2-5DC0-4C6C-9E93-4A41F6AFA2D9

P356

Q28346140-834FA856-D7F5-40A0-B158-D994828686EB

P407

Q28346140-C58ABF67-383D-4BCB-B22F-38BA6BC787C6

P433

Q28346140-7F81C944-5220-4347-9114-BD9D4F0B5E87

P478

Q28346140-013A6C7D-D1B5-40C2-92E8-07F2E2EE1087

P577

Q28346140-361968E6-038E-4C6A-90BB-77BD01CE8B98

P698

Q28346140-AAB7B670-659C-4B69-80C1-302F26ABC936

P921

Q28346140-0EAAF838-02C6-44E2-A752-D12786C04712

Q28346140-35BDF8F1-62F3-40A4-86F7-FC08347AE08B

P932

Q28346140-33F7B4BC-8158-49AD-A5A0-09A90E5C5423

P3181

P356

AAC.45.2.639-640.2001

P1433

Antimicrobial Agents and Chemotherapy

P1476

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

@en

P2093

G K Khuller

http://www.w3.org/2001/XMLSchema#string

I Verma

http://www.w3.org/2001/XMLSchema#string

S Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils

Antibiotic peptides from higher eukaryotes: biology and applications.

Monocyte-chemotactic activity of defensins from human neutrophils.

In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis

Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare

Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation

Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study.

P304

639-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3433298

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/AAC.45.2.639-640.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11158773

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

infectious disease

P932

90345

http://www.w3.org/2001/XMLSchema#string